Navigation Links
Therapeutic Drug Monitoring - Technologies, Markets, and Companies - 2013
Date:7/31/2013

DUBLIN, Ireland, July 31, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/jnrdbv/therapeutic_drug) has announced the addition of a new report "Therapeutic Drug Monitoring - Technologies, Markets, and Companies" to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

This report deals with therapeutic drug monitoring, a multi-disciplinary clinical specialty, aimed at improving patient care by monitoring drug levels in the blood to individually adjust the dose of drugs for improving outcome. TDM is viewed as a component of personalized medicine that interacts with several other disciplines including pharmacokinetics and pharmacogenetics. One chapter is devoted to monitoring of drugs of abuse (DoA). Various technologies used for well-known DoA are described. A section on drug abuse describes methods of detection of performance-enhancing drugs. TDM market is analyzed from 2011 to 2021 according to technologies as well as geographical distribution. Global market for DoA testing was also analyzed from 2011 to 2021 and divided according to the area of application. Unmet needs and strategies for development of markets for TDM are discussed. The report contains profiles of 27 companies involved in developing tests and equipment for drug monitoring along with their collaborations. The text is supplemented with 17 tables, 6 figures and 150 selected references from literature.

Benefits of this report

- Up-to-date one-stop information on therapeutic drug monitoring
- Description of 27 companies involved with their collaborations in this area
- Market analysis 2012-2022/
- Market values in major regions
- Strategies for developing markets for therapeutic drug monitoring
- A selected bibliography of 150 publications
- Text is supplemented by 17 tables and 6 figures


Who should read this report?

- Biotechnology companies developing assays and equipment for drug monitoring
- Reference laboratories providing drug monitoring services
- Pharmaceutical companies interested in companion tests for monitoring their drugs
- Clinical pharmacologists interested in integrating therapeutic drug monitoring with pharmacogenetics for development of personalized medicine

Key Topics Covered:

Executive Summary

1. Introduction

2. Technologies for TDM

3. Drug Monitoring Instruments

4. Applications of TDM

5. Drugs Requiring Monitoring

6. Monitoring of Biological Therapies

7. Monitoring of Drug Abuse

8. Markets for TDM

9. Companies

10. References

For more information visit http://www.researchandmarkets.com/research/jnrdbv/therapeutic_drug

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals



'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Diabetes Therapeutics Market in India to 2018 - Rapid Uptake of DPP-IV Inhibitors, GLP-1 Agonists and Expanding Insulin Segment to Drive Growth
2. Serina Therapeutics Announces Agreement with the Scripps Research Institute for Development of Polymer-Antibody Drug Conjugates
3. Advanced Prenatal Therapeutics Appoints Dr. Nihar Nayak to its Scientific Advisory Board
4. Signature Therapeutics Receives BrIDGs Award to Advance Its Abuse-Deterrent Oxycodone, PF614
5. aTyr Pharma Completes $49 Million Financing to Advance a Therapeutic Pipeline for Rare Autoimmune Diseases from a Newly Discovered Class of Proteins, Physiocrines
6. Orexigen Therapeutics to Host Second Quarter 2013 Financial Results Conference Call and Webcast
7. Intarcia Therapeutics Appoints Gino Santini To Its Board Of Directors
8. Frost & Sullivan: Molecular Farming Fits Need for Fully Functional Protein Therapeutics and Low-Cost Vaccines
9. Galectin Therapeutics Announces First Patient Dosed in Phase 1 Trial of GR-MD-02, a Potential First-in-Class Treatment for Fatty Liver Disease with Advanced Fibrosis
10. Distinguished Cancer Investigator, Daniel Von Hoff, M.D., to Lead Cell Therapeutics Scientific Advisory Board
11. Cell Therapeutics to Report Second Quarter Financial Results after Market on July 31, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2017)...  Researchers from DRUGSCAN ® and INC Research ... live, complimentary webinar titled, "Untangling methods to tamper with ... world" on Wednesday June 28, 2017 from 12:00 PM ... will feature interviews with recreational and dependent prescription opioid ... abusers use to prepare opioid tablets for routes of ...
(Date:6/14/2017)... 14, 2017  In 2016, Embodied Labs ... pitch competition and came away with $25,000 in seed-fund ... by Forbes as "entering the life of another" and ... teaching "empathy to medical professionals in an entirely new ... named a finalist for the Department of Education,s EdSimChallenge, ...
(Date:6/9/2017)... Calif. , June 9, 2017 AirXpanders, ... company focused on the design, manufacture, sale and distribution ... market on the progress of its commercial roll-out in ... now available in more than one hundred (100) medical ... AeroForm offers a needle-free alternative for women ...
Breaking Medicine Technology:
(Date:6/23/2017)... ... June 23, 2017 , ... Jusino Insurance Services, a locally ... the greater Chicago metropolitan area, is embarking on a charity drive in conjunction ... , Founded in 1897, Hephzibah Children’s Association is one of the oldest social ...
(Date:6/22/2017)... ... June 22, 2017 , ... Plastic Surgery Associates is ... Top Doctor for 2017. Each year, research and information firm, Castle Connolly, releases their ... title in 2015, this marks the 3rd time that Dr. Canales has ...
(Date:6/22/2017)... ... June 22, 2017 , ... The VA Maryland ... Recycling Network has awarded the Baltimore VA Medical Center, a division of the ... for its efforts to promote waste reduction and promote recycling. Also, Practice ...
(Date:6/20/2017)... ... 2017 , ... Connance, a leading provider of healthcare predictive ... analytics drive reimbursement optimization, with a focus on denial management and claims statusing, ... traditional approach to denied and underpaid claims leaves money on the table and ...
(Date:6/20/2017)... ... June 20, 2017 , ... Fresenius Vascular Care, a national ... techniques to treat and manage a wide range of vascular conditions, has today announced ... more than 65 centers represented by more than 40 local brands, a phased rollout ...
Breaking Medicine News(10 mins):